» Articles » PMID: 32093640

Temporal Changes in Gut Microbiota Profile in Children with Acute Lymphoblastic Leukemia Prior to Commencement-, During-, and Post-cessation of Chemotherapy

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2020 Feb 26
PMID 32093640
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alteration in gut microbiota has been recently linked with childhood leukemia and the use of chemotherapy. Whether the perturbed microbiota community is restored after disease remission and cessation of cancer treatment has not been evaluated. This study examines the chronological changes of gut microbiota in children with acute lymphoblastic leukemia (ALL) prior to the start-, during-, and following cessation of chemotherapy.

Methodology: We conducted a longitudinal observational study in gut microbiota profile in a group of paediatric patients diagnosed with ALL using 16 s ribosomal RNA sequencing and compared these patients' microbiota pattern with age and ethnicity-matched healthy children. Temporal changes of gut microbiota in these patients with ALL were also examined at different time-points in relation to chemotherapy.

Results: Prior to commencement of chemotherapy, gut microbiota in children with ALL had larger inter-individual variability compared to healthy controls and was enriched with bacteria belonging to Bacteroidetes phylum and Bacteroides genus. The relative abundance of Bacteroides decreased upon commencement of chemotherapy. Restitution of gut microbiota composition to resemble that of healthy controls occurred after cessation of chemotherapy. However, the microbiota composition (beta diversity) remained distinctive and a few bacteria were different in abundance among the patients with ALL compared to controls despite completion of chemotherapy and presumed restoration of normal health.

Conclusion: Our findings in this pilot study is the first to suggest that gut microbiota profile in children with ALL remains marginally different from healthy controls even after cessation of chemotherapy. These persistent microbiota changes may have a role in the long-term wellbeing in childhood cancer survivors but the impact of these changes in subsequent health perturbations in these survivors remain unexplored.

Citing Articles

LC-MS analysis of serum lipidomic and metabolomic signatures in pediatric patients with acute lymphoblastic leukemia.

Yan F, Wang S, Wang Y, Sun Y, Yang J, Sun L Ital J Pediatr. 2025; 51(1):74.

PMID: 40075508 PMC: 11905700. DOI: 10.1186/s13052-025-01921-z.


Understanding gut Microbiome changes in Korean children, adolescents, and young adults with hematologic malignancies.

Park M, Jung J, Lee J, Lee E, Lee H, Eom H Ann Hematol. 2025; .

PMID: 40069438 DOI: 10.1007/s00277-025-06293-2.


Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review.

Todor S, Ichim C Children (Basel). 2025; 12(2).

PMID: 40003268 PMC: 11854176. DOI: 10.3390/children12020166.


The pros and cons of probiotic use in pediatric oncology patients following treatment for acute lymphoblastic leukemia.

Simiakova M, Bielik V Front Pediatr. 2024; 12:1427185.

PMID: 39502562 PMC: 11534854. DOI: 10.3389/fped.2024.1427185.


The emerging role of in diarrhea: where we stand.

Khaledi M, Saghabashi A, Ghahramanpour H Germs. 2024; 14(2):179-188.

PMID: 39493745 PMC: 11527489. DOI: 10.18683/germs.2024.1429.


References
1.
Jones R, Zhu X, Moan E, Murff H, Ness R, Seidner D . Inter-niche and inter-individual variation in gut microbial community assessment using stool, rectal swab, and mucosal samples. Sci Rep. 2018; 8(1):4139. PMC: 5841359. DOI: 10.1038/s41598-018-22408-4. View

2.
Bassis C, Moore N, Lolans K, Seekatz A, Weinstein R, Young V . Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. BMC Microbiol. 2017; 17(1):78. PMC: 5374586. DOI: 10.1186/s12866-017-0983-9. View

3.
Caporaso J, Lauber C, Walters W, Berg-Lyons D, Lozupone C, Turnbaugh P . Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4516-22. PMC: 3063599. DOI: 10.1073/pnas.1000080107. View

4.
Geuking M, Koller Y, Rupp S, McCoy K . The interplay between the gut microbiota and the immune system. Gut Microbes. 2014; 5(3):411-8. PMC: 4153781. DOI: 10.4161/gmic.29330. View

5.
Rajagopala S, Yooseph S, Harkins D, Moncera K, Zabokrtsky K, Torralba M . Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis. BMC Genomics. 2016; 17(1):635. PMC: 4986186. DOI: 10.1186/s12864-016-2965-y. View